Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Michetti

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
United European Gastroenterology Journal|November 18, 2020
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurementsOrla Mader, Pascal Juillerat, Luc Biedermann, et al.
International Journal of Epidemiology|January 29, 2019
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)Valérie Pittet, Pierre Michetti, Christoph Mueller, et al.
Digestion|July 31, 2014
Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendationsBernhard Sauter, Christoph Beglinger, Marc Girardin, et al.
Digestion|April 13, 2007
Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approachIdris Guessous, Pascal Juillerat, Valerie Pittet, et al.
Digestion|May 29, 2013
Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's diseaseValerie Pittet, Gerhard Rogler, Pierre Michetti, et al.
Swiss Medical Weekly|December 5, 2019
Position statement on the use of biosimilars in inflammatory bowel diseaseEmanuel Burri, Pascal Juillerat, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|December 18, 2014
Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts?Valérie Pittet, Michel H Maillard, Stéphanie Lauvergeon, et al.
Behavioural Neurology|June 1, 2007
Perceived behavioral changes in early multiple sclerosisFabiana Souza Lima, Samanta Simioni, Laure Bruggimann, et al.
Journal of Crohn'S & Colitis|October 18, 2018
Vedolizumab in Refractory Microscopic Colitis: An International Case SeriesPauline Rivière, Andreas Münch, Pierre Michetti, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort studyPascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
United European Gastroenterology Journal|November 18, 2020
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurementsOrla Mader, Pascal Juillerat, Luc Biedermann, et al.
International Journal of Epidemiology|January 29, 2019
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)Valérie Pittet, Pierre Michetti, Christoph Mueller, et al.
Digestion|July 31, 2014
Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendationsBernhard Sauter, Christoph Beglinger, Marc Girardin, et al.
Digestion|April 13, 2007
Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approachIdris Guessous, Pascal Juillerat, Valerie Pittet, et al.
Digestion|May 29, 2013
Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's diseaseValerie Pittet, Gerhard Rogler, Pierre Michetti, et al.
Swiss Medical Weekly|December 5, 2019
Position statement on the use of biosimilars in inflammatory bowel diseaseEmanuel Burri, Pascal Juillerat, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|December 18, 2014
Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts?Valérie Pittet, Michel H Maillard, Stéphanie Lauvergeon, et al.
Behavioural Neurology|June 1, 2007
Perceived behavioral changes in early multiple sclerosisFabiana Souza Lima, Samanta Simioni, Laure Bruggimann, et al.
Journal of Crohn'S & Colitis|October 18, 2018
Vedolizumab in Refractory Microscopic Colitis: An International Case SeriesPauline Rivière, Andreas Münch, Pierre Michetti, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort studyPascal Juillerat, Valérie Pittet, Jean-Luc Bulliard, et al.
Pageof 15